Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies

Advanced Science(2022)10.1002/advs.202103677Source: DataRank Database

Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies is a research paper published in Advanced Science (2022). On theSindex it has a DataRank of 0. It has been cited 49 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access49 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 3.24)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Emily L. Meany ORCID,Emily C. Gale ORCID,John H. Klich ORCID,Olivia M. Saouaf ORCID,Aaron T. Mayer ORCID

Live enrichment

PubMed:35975424 PMC:PMC9534946 OpenAlex:https://openalex.org/W4292080826

American Cancer Society

Grant: RSG‐18‐133‐01‐CDD

National Institutes of Health

Grant: F32CA247352

NIGMS NIH HHS

Grant: T32 GM007276

NIH Cell and Molecular Biology Training Program

Grant: T32 GM007276

American Cancer Society

Grant: RSG-18-133-01-CDD

NCI NIH HHS

Grant: P30 CA124435

Goldman Sachs Foundation

Grant: 162509

NIGMS NIH HHS

Grant: T32 GM008412

NIH Biotechnology Training Program

Grant: T32 GM008412

National Cancer Institute

National Science Foundation

National Defense and Science Engineering Graduate

FWCI

3.24

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202103677

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202103677

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202103677

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/advs.202103677

publisherhttps://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202103677

Fields of Study

Immunotherapy and Immune ResponsesCAR-T cell therapy researchCancer Immunotherapy and Biomarkers

MeSH Terms

AntibodiesHumansMelanomaPolymersTomography, X-Ray ComputedCytokinesCD40 AntigensHydrogelsNanoparticles

Keywords

Self-healing hydrogelsImmunotherapyImmune systemMedicineCytokine stormDrug deliveryTumor microenvironmentCancer researchPharmacologyImmunologyNanotechnologyChemistryMaterials scienceInternal medicineCoronavirus disease 2019 (COVID-19)DiseaseCancerPharmacokineticsBiomaterials

Sustainable Development Goals

SDG 0: Good health and well-being

Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies

FAIR Checklist

Authors (14)

Funding (12 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)